S.D. Anker

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Paul M. Ridker, Jean MacFadyen, Peter Libby et al. · The Lancet · 2017 · 886 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +8

In-Hospital and 1-Year Mortality Associated with Diabetes in Patients with Acute Heart Failure: Results from the ESC-HFA Heart Failure Long-Term Registry

Giovanni Targher, Marco Dauriz, Cécile Laroche et al. · European Journal of Heart Failure · 2016 · 171 citations · Full text

Medicine, Cardiology, Internal Medicine +8

Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry

Marco Dauriz, Giovanni Targher, Cécile Laroche et al. · Diabetes Care · 2017 · 142 citations · Full text

Medicine, Cardiology, Internal Medicine +17

Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform: Report of a policy conference of the European Society of Cardiology

Alan G. Fraser, Jean Claude Daubert, Frans Van de Werf et al. · European Heart Journal · 2011 · 78 citations · Full text

Engineering, Cardiology, Health Policy +17